Pure Global
NCT06210009

Effect of a DASH-Style Diet on Urinary Risk Factors for Kidney Stone Disease

Effect of a DASH-Style Diet on Urinary Risk Factors for Kidney Stone Disease: A Randomized Controlled Trial (CARDIA Ancillary Study)
University of Alabama at Birmingham·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Kidney Stone
Drug/Device/Intervention
DASH-Style Diet
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
University of Alabama at Birmingham
Location
Birmingham, United States of America
Timeline & enrollment
Phase
N/A
Start date
May 01, 2024
End date
Aug 31, 2027
Enrollment
45 participants
Primary outcome

Difference between the two arms in supersaturation of calcium oxalate

Summary

The true capacity for a healthy diet to improve urinary stone risk factors is not
 well-defined. The objective of this study is to measure the effect of adopting a healthy
 dietary pattern on kidney stone disease (KSD) risk. The working hypothesis is that a Dietary
 Approaches to Stop Hypertension (DASH)-style diet will improve 24-hour urine stone risk
 parameters. The approach to testing this hypothesis will be to randomize participants with
 KSD to a standardized DASH-style vs. Western-style diet for one week. The Bionutrition Unit
 of the Center for Clinical and Translational Science will provide all meals to participants.
 The rationale for this study is that by measuring the effect of a DASH-style diet on urinary
 stone risk parameters, a benchmark for future real-world, implementation studies will be
 established. Based on available evidence, this will be the first controlled diet study to
 assess the DASH dietary pattern for improving urinary stone risk parameters.

ICD-10 classifications
Kidney dialysisSmall kidney, unspecifiedDisorder of kidney and ureter, unspecifiedInjury of kidneyUnspecified kidney failure
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06210009
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06210009 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Alabama at Birmingham and is currently Not yet recruiting. The study focuses on Kidney Stone. Target enrollment is 45 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.